Evidence map›Paper›PMID 19864299›Full record

ArticleAmerican journal of physiology. Renal physiology2010

Reductions in laminin beta2 mRNA translation are responsible for impaired IGFBP-5-mediated mesangial cell migration in the presence of high glucose.

Valerie Schaeffer, Kim M Hansen, David R Morris, Christine K Abrass

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Valerie SchaefferPrimary and Specialty Care Medicine, Department of Veterans Affairs Puget Sound Health Care System, University of Washington School of Medicine, Seattle, Washington 98109, USA.
Kim M Hansen
David R Morris
Christine K Abrass
VA Puget Sound Health Care System · USUniversity of Washington · US

Funding

GLOMERULAR LAMININS: STRUCTURE AND FUNCTIONR01DK049771 · NIDDK · UNIVERSITY OF WASHINGTON · PI ABRASS, CHRISTINE KREGER · 1996 to 2003
$888k
NIDDK NIH HHS R01-DK49771
6 · The paper itself

Abstract

Insulin-like growth factor binding protein-5 (IGFBP-5) mediates mesangial cell migration through activation of cdc42, and laminin421 binding to alpha(6)beta(1)-integrin (Berfield AK, Hansen KM, Abrass CK. Am J Physiol Cell Physiol 291: C589-C599, 2006). Because glomerular expression of laminin beta(2) is reduced in diabetic rats (Abrass CK, Spicer D, Berfield AK, St. John PL, Abrahamson DR. Am J Pathol 151: 1131-1140, 1997), we directly examined the effect of hyperglycemia on mesangial cell migration and laminin beta2 expression. Migration mediated by IGFBP-5 is impaired in the presence of 25 mM glucose. This reduction in migration was found to result from a loss in mesangial cell synthesis of laminin421, and IGFBP-5-induced migration could be restored by replacing laminin421. Additional studies showed that there was selective reduction in mRNA translation of laminin beta2 in the presence of high glucose. Preserved synthesis of laminin beta1 indicates that not all proteins are reduced by high glucose and confirms prior data showing that laminin411 cannot substitute for laminin421 in IGFBP-5-mediated migration. Given the importance of mesangial migration in the reparative response to diabetes-associated mesangiolysis, these findings provide new insights into abnormalities associated with diabetic nephropathy and the potential importance of differential control of protein translation in determination of alterations of protein expression.

Indexed as

Protein BiosynthesisAnimalsCell MovementCells, CulturedDiabetic NephropathiesDose-Response Relationship, DrugDown-RegulationDrug Administration ScheduleExtracellular Matrix ProteinsGlucoseHyperglycemiaInsulin-Like Growth Factor Binding Protein 5LamininMesangial CellsRatsRNA, MessengerExtracellular Matrix ProteinsGlucoseInsulin-Like Growth Factor Binding Protein 5Lamininlaminin beta2RNA, Messenger

Identifiers

PMID19864299
PMCPMC2822519
OpenAlexW2141206039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.